TGFB1 and atrial fibrillation: TGF-β1 overexpression in normal hearts induced atrial fibrosis and enhanced incidence of atrial fibrillation in mice [4], whereas blocking TGF-β1-dependent signalling improved cardiac function and inhibited cardiac fibrosis in vivo [5, 6].